Skip to main content
main-content
Top

09-10-2017 | Dabrafenib | Article

Long-Term Outcomes in Patients With BRAF V600-Mutant Metastatic Melanoma Who Received Dabrafenib Combined With Trametinib

Long G et al. J Clin Oncol 2018; 36(7): 667-673. doi:10.1200/JCO.2017.74

Please log in to get access to this content

Related topics